InvestorsHub Logo
Followers 155
Posts 2632
Boards Moderated 0
Alias Born 01/29/2004

Re: abew4me post# 432491

Saturday, 09/23/2023 8:15:15 PM

Saturday, September 23, 2023 8:15:15 PM

Post# of 461430
The new Anavex professionals tell the real story.

...you can't dispute that Dr. Missling is putting his money where his mouth is.


Yes, the CEO owns millions of shares of AVXL. Few others will have lost as much value if Anavex Life Sciences fails.

But what about the new executive, Dr. Kun Jim? This medical research expert, with profound expertise in biostatistics, would surely seem to be jeopardizing his credentials and career if Anavex doesn’t have the clinical data to support FDA approval of blarcamesine for something.

Same for Dr. Marwan Sabbagh as new Chairman of Anavex’s Scientific Advisory Board. Why ever would this renowned fellow desire to be connected to, associated with Anavex Life Sciences Corp, if the company has nothing the FDA can approve?

Where do you suppose either of these gentlemen went to learn about Anavex Life Sciences Corp when they were considering the offers Dr. Missling invited their professional association with Anavex Life Sciences Corp? Suppose they went to this message board to get Anavex’s real story?

Or, per chance, is there any possibility that Missling showed both of these gentlemen every fragment of clinical data the company has accumulated? What about yet-unrevealed data the company has accumulated about the entirety of sigma-1 biology when modulated by the company’s proprietary molecules?

I appreciate and consider the variety of commentaries posted on this message board. But, altogether, I’m with these two bioresearch professionals. Neither would have signed on if Anavex had the deficiencies so frequently proposed on this message board. Just the opposite.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News